- Report
- July 2023
- 257 Pages
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- March 2024
- 199 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- May 2024
- 504 Pages
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- December 2023
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 170 Pages
Global
€4803EUR$4,995USD£4,120GBP
- Report
- October 2021
- 55 Pages
Global
From €1899EUR$1,975USD£1,629GBP
€3798EUR$3,950USD£3,258GBP
- Report
- March 2023
- 180 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- August 2018
- 15 Pages
Global
- Report
- September 2018
- 15 Pages
Global
- Report
- April 2018
- 15 Pages
Global
- Report
- April 2023
- 120 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- December 2022
- 326 Pages
Global
From €3462EUR$3,600USD£2,970GBP
- Report
- November 2021
- 527 Pages
Global
From €3846EUR$4,000USD£3,299GBP
- Report
- November 2021
- 1165 Pages
Global
From €5769EUR$6,000USD£4,949GBP
- Report
- March 2020
- 112 Pages
Global
From €4135EUR$4,300USD£3,547GBP
- Book
- September 2012
- 688 Pages
- Book
- July 2011
- 396 Pages
- Book
- November 2008
- 496 Pages
- Book
- June 2023
- 448 Pages
Toxicogenomics is a field of genomics that focuses on the study of the effects of environmental toxins on gene expression. It combines toxicology and genomics to understand how exposure to environmental toxins can cause changes in gene expression and lead to adverse health effects. Toxicogenomics is used to identify biomarkers of exposure and toxicity, as well as to develop new methods for assessing the safety of chemicals and drugs. It is also used to identify potential targets for drug development and to develop new strategies for risk assessment.
Toxicogenomics is an important tool for understanding the effects of environmental toxins on human health. It can be used to identify potential health risks associated with exposure to environmental toxins, as well as to develop new strategies for risk assessment and drug development.
Companies in the toxicogenomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, QIAGEN, and Bio-Rad Laboratories. Show Less Read more